In sepsis, Escherichia coli-derived LPS activates RIPK1, RIPK3, and MLKL in intestinal epithelial cells, causing severe barrier disruption—an effect attenuated by RIPK1 inhibition using necrostatin-1 (Nec-1) (Liu et al., 2021). The gene discussed is RIPK1; the disease is Sepsis.